INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS?
This review presents information on pharmaceuticals that have the properties of inverse agonists. The article describes the features of the interaction of the ligand - receptor with constitutive conformational changes. Many of ligands, assumed to be neutral antagonists, behave as inverse agonists di...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_8dda3d9359cc4b578a6f80c5f3c0c323 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a R. N. Alyautdin |e author |
| 700 | 1 | 0 | |a B. K. Romanov |e author |
| 245 | 0 | 0 | |a INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS? |
| 260 | |b Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», |c 2022-06-01T00:00:00Z. | ||
| 500 | |a 2312-7821 | ||
| 500 | |a 2619-1164 | ||
| 520 | |a This review presents information on pharmaceuticals that have the properties of inverse agonists. The article describes the features of the interaction of the ligand - receptor with constitutive conformational changes. Many of ligands, assumed to be neutral antagonists, behave as inverse agonists displaying negative efficacy in experimental systems. This suggests that their therapeutic actions may involve not only receptor blockade, but also the decrease of spontaneous receptor activity. Examples of inverse agonists that influence the processes of excitation of adrenergic, histaminergic, opioid and benzodiazepine receptors are presented. The existence of constitutive activity in vivo and its pathophysiological relevance are also discussed | ||
| 546 | |a RU | ||
| 690 | |a inverse agonists, rimonabant, intrinsic activity, constitutive activity | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Безопасность и риск фармакотерапии, Vol 0, Iss 4, Pp 6-11 (2022) | |
| 787 | 0 | |n https://www.risksafety.ru/jour/article/view/314 | |
| 787 | 0 | |n https://doaj.org/toc/2312-7821 | |
| 787 | 0 | |n https://doaj.org/toc/2619-1164 | |
| 856 | 4 | 1 | |u https://doaj.org/article/8dda3d9359cc4b578a6f80c5f3c0c323 |z Connect to this object online. |